ANTISENSE MODULATION OF FARNESOID X RECEPTOR EXPRESSION

Details for Australian Patent Application No. 2003283966 (hide)

Owner PHARMACIA CORPORATION

Inventors KANE, Christopher, D.

Pub. Number AU-A-2003283966

PCT Number PCT/US2003/0303

PCT Pub. Number WO2004/030750

Priority 60/413,588 25.09.02 US

Filing date 25 September 2003

Wipo publication date 23 April 2004

International Classifications

A61N 001/05 Electrotherapy - for implantation or insertion into the body, e.g. heart electrode

Event Publications

25 March 2004 Complete Application Filed

  Priority application(s): 60/413,588 25.09.02 US

27 May 2004 Application Open to Public Inspection

  Published as AU-A-2003283966

21 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003283967-CRITICAL PHASE ALKYLATION PROCESS

2003283965-DRILL SHARPENER